INTRODUCTION AND OBJECTIVES: Primary macronodular adrenal hyperplasia (PMAH) is a rare cause of Cushing's syndrome (CS). Currently, bilateral adrenalectomy is the standard option for patients with PMAH associated with CS but leads to lifetime adrenal insufficiency. In order to overcome the hormonal replacement caveats while minimizing the risks of hypercortisolism relapse, we performed a series of simultaneous total adrenalectomy of largest adrenal gland and contralateral partial adrenalectomy (adrenal sparing surgery) to treat patients with PMAH.
INTRODUCTION AND OBJECTIVES: Primary macronodular adrenal hyperplasia (PMAH) is a rare cause of Cushing's syndrome (CS). Currently, bilateral adrenalectomy is the standard option for patients with PMAH associated with CS but leads to lifetime adrenal insufficiency. In order to overcome the hormonal replacement caveats while minimizing the risks of hypercortisolism relapse, we performed a series of simultaneous total adrenalectomy of largest adrenal gland and contralateral partial adrenalectomy (adrenal sparing surgery) to treat patients with PMAH.
METHODS: Seventeen patients diagnosed with PMAH were treated surgically with adrenal sparing surgery. Primary endpoint was hypercortisolism control and return of physiologic function of hypotalamum-ptuitary-adrenal (HPA) axis, considered when patients had physiologic cortisol levels (5-25 mg/L) without hormonal reposition. Adrenal insufficiency was defined when oral hydrocortisone reposition was needed. Secondary endpoints were clinical and metabolic parameters improvement. Body mass index (BMI), blood pressure, cholesterol, lipid and glucose levels, were measured before, 12 months after the procedure and in the last visit. Medications were also assessed and compared before and after surgery.
RESULTS: There were no intra-operative complications and average operation time was 199 AE 34 minutes. With a median followup of 37 months (range: 13 to 63 months), 95% of the cohort had complete hypercortisolism control, 70.5% reached normal cortisol levels and 29.5% remain in adrenal insufficiency. Hypercortisolism recurrence was observed in one patient. Measurable ACTH was important factor to predict the time of HPA axis recovery (p[0.03; RR[12.15) METHODS: The total RNA of 15 patients with adrenal aldosterone tumor were collected after operation from aldosterone tumor and adjacent normal adrenal gland. The expression of mir-140-3p, mir193a-3p, mir-22-3p and CYP11B2 mRNA were detected by quantitative reverse transcription PCR (qrt-pcr). Cultured adrenocortical cell line H295R and transfected with mir-193a-3p. Cell proliferation was detected by colorimetry and apoptosis and cell cycle progression were analyzed by flow cytometry. The levels of aldosterone in the supernatant were detected by ELISA.
RESULTS: By detecting three miRNAs, miR-193a-3p expression was significantly decreased and CYP11B2 mRNA expression was significantly increased in APA compared with adjacent normal adrenal tissue. The miR-193a-3p mimic was transfected into the human adrenocortical cell line H295R, and it was found that increased expression of miR-193a-3p inhibited cell proliferation and aldosterone secretion, induced G1 arrest and promoted apoptosis of H295R cells. In addition, by luciferase gene assay, overexpression of miR-193a-3p in H295R cells significantly reduced the luciferase activity of the wild-type CYP11B2 3'-UTR construct and found that it can pass miR-193a-Reversal of mutation of the 3p binding site. In addition, miR-193a-3p overexpression downregulated the expression of CYP11B2 mRNA and protein. Finally, overexpressed CYP11B2 attenuated the effect of miR-193a-3p on H295R cells. CONCLUSIONS: Our study suggests that miR-193a-3p may be involved in down-regulating the expression of CYP11B2 and inhibiting APA growth. This also explains that down-regulation of miR-193a-3p promotes cell growth and inhibits apoptosis during APA formation.
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MP69-06 RISK FACTORS FOR HEMODYNAMIC INSTABILITY DURING LAPAROSCOPIC ADRENALECTOMY FOR PHEOCHROMOCYTOMA.
Toshikazu Takeda*, Kimiharu Takamatsu, Yu Teranishi, Kyohei Hakozaki, Nobuyuki Tanaka, Kazuhiro Matsumoto, Shinya Morita, Takeo Kosaka, Ryuichi Mizuno, Toshiaki Shinojima, Eiji Kikuchi, Hiroshi Asanuma, Mototsugu Oya, Tokyo, Japan INTRODUCTION AND OBJECTIVES: Pheochromocytoma is a rare neuroendocrine tumor that secretes catecholamines and mainly originates in the adrenal grand. Surgical resection is the only curative therapy for pheochromocytoma; however, it is associated with a risk of the massive release of catecholamines, which causes extremely high blood pressure. Furthermore, tumor resection resulting in the acute withdrawal of catecholamines leads to hypotension and shock. In the present study, we evaluated factors affecting hemodynamic instability (HI) during laparoscopic adrenalectomy for pheochromocytoma.
METHODS: Fifty-three patients who underwent laparoscopic adrenalectomy for pheochromocytoma between March 2009 and October 2018 were evaluated. We excluded 10 patients who did not have detailed 24-hour urinary data. The administration of a nonselective a-adrenergic receptor blocker was initiated preoperatively in all patients. We defined HI as extremely high or low blood pressure during surgery, with systolic blood pressure higher than 200 mmHg or lower than 80 mmHg. We examined factors affecting HI during laparoscopic adrenalectomy for pheochromocytoma. Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e985
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